BioSpace News Archive

Alpha Cancer Technologies Inc. (ACT) today announced details from the company’s abstract published as part of the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting.

At the 2023 ASCO Annual Meeting, Agendia, Inc., a gene expression profiling company advancing personalized early-stage breast cancer care, reinforces its commitment to progressing research of racial disparities in breast cancer through two poster presentations.

Reneo Pharmaceuticals, Inc. announced that the company’s management team will participate at the Jefferies Healthcare Conference.

USA News Group - With this year’s Annual Meeting of the American Society of Clinical Oncology (ASCO 2023) less than 30 days away, there’s plenty of anticipation for updates on some of the biggest developments in the world of cancer research.

GeneCentric Therapeutics, a company making precision medicine more precise through RNA-based diagnostics, announced today that its PurIST℠ test is now commercially available through Tempus for clinical use.

Peak Pharmaceuticals, Inc., announced that its wholly owned subsidiary, Retrieve Medical, Inc., has signed an agreement with a 100-bed regional medical center with approximately 1,000 providers in the Southern area of the U.S. Retrieve plans to immediately begin the implementation phase of their patented software solution.

According to our latest study on “Virology Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Type, Application, End User, and Geography,” the Virology Market is projected to reach US$ 5,276.48 million by 2028 from US$ 4,108.27 million in 2021;

According to our new research study on “Cell Therapy Market to 2027 – Global Analysis and Forecast – by Therapy Type, Product, Technology, Application and End User,” the Cell Therapy Market was valued at US$ 7,260.50 million in 2019 and is projected to reach US$ 12,563.23 million by 2027;

According to our new research study on “Gastroparesis Market to 2027 – Global Analysis and Forecast – by Gastroparesis Type, Drug Class Type, and Distribution Channel,” the Gastroparesis Market was valued at US$ 4,338.61 million in 2019 and is projected to reach US$ 6,025.11 million by 2027;

Tampa General Hospital announced that doctors at the academic health system had performed the first living donor liver transplant on the West Coast of Florida.